A type 1 diabetic patient with unilateral active thyroid-related eye
disease was intolerant to systemic steroid therapy due to uncontrollable
blood sugar levels. She was treated with low-dose methotrexate
monotherapy which resulted in a marked improvement of her condition with
no adverse events.